Danazol Once Weekly
Drugsemi-solid
NCT Number: NCT00758953
This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Phase 2
Kelowna, British Columbia, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
semi-solid
semi-solid
semi-solid
semi-solid
Time frame: 3 months of treatment
Lumara Health, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07241637
Endometriosis, Fatigue
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05962034
Endometriosis, Female Urogenital Diseases
University Park, Pennsylvania, United States
View Trial DetailsNCT05019612
Endometriosis, Expectations
Hamburg, Germany
View Trial DetailsNCT00073801
Chronic Pelvic Pain, Endometriosis
Bethesda, Maryland, United States
View Trial Details